15 results on '"Yu, Zhiyong"'
Search Results
2. The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
3. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer
4. Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer
5. Preoperative tumor biopsy results in more detected sentinel nodes than intraoperative biopsy in breast cancer patients
6. Real‐world treatment patterns and outcomes of pyrotinib‐based therapy in patients with HER2‐positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.
7. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.
8. Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment.
9. EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling.
10. Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer.
11. Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer
12. Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.
13. The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer.
14. Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].
15. Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.